To give consent online, your child's school needs to share their records (including your NRIC/FIN) with us. This is done only with parental consent.

If your child's records aren't showing up, their school might not have shared them yet.

From 1 January 2027, in line with changes to the NCIS, the HPV 9 vaccine (Gardasil 9) will replace the HPV 2 vaccine (Cervarix)* under the National School-Based Human Papillomavirus (HPV) Vaccination Programme for female students who have not yet started or completed their vaccination series. Students who started on the HPV2 vaccine (Cervarix) may complete their series with HPV9 (Gardasil 9), as mixed vaccine schedules have been shown to be effective against HPV types 16 and 18 and have acceptable safety profiles.

If you want your child to receive the HPV vaccination under the school-based programme, please try sending your consent online again.

*While both the HPV2 (Cervarix) and HPV9 (Gardasil 9) vaccines provide comparable protection against HPV types 16 and 18, which are responsible for 70% of cervical cancers, the HPV9 vaccine also protects against HPV types responsible for an additional 20% of cervical cancers, providing broader coverage than the HPV2 vaccine.